We hypothesise that these PDGFRα-expressing cMSCs (PDGFRα + cMSCs) are linked to cardiac disease through processes of inflammation and fibrosis, and therefore represent potential therapeutic targets. This evidence concerns the gene PDGFRA and heart disorder.